SLS Return on Tangible Equity | SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc. (SLS) Return on Tangible Equity

2026-06-30: Return Tang Equity -23.91%.
2026-03-31: Return Tang Equity -27.92%.
2025-12-31: Return Tang Equity -38.96%.
2025-09-30: Return Tang Equity -59.34%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-23.91%
2026-03-31	-27.92%
2025-12-31	-38.96%
2025-09-30	-59.34%
2025-06-30	-108.35%
2025-03-31	-104.96%
2024-12-31	-408.97%
2024-09-30	-230.93%
2024-06-30	-3447.35%
2024-03-31	-460.86%
2023-12-31	377.55%
2023-09-30	667.57%
2023-06-30	-1231.82%
2023-03-31	-316.78%
2022-12-31	-1406.23%
2022-09-30	-362.99%
2022-06-30	-226.57%
2022-03-31	-1659.88%
2021-12-31	-112.29%
2021-09-30	-93.81%
2021-06-30	-58.93%
2021-03-31	-71.08%
2020-12-31	-82.36%
2020-09-30	176.90%
2020-06-30	128.34%
2020-03-31	165.02%
2019-12-31	143.74%
2019-09-30	283.83%
2019-06-30	411.21%
2019-03-31	146.17%
2018-12-31	193.92%
2018-09-30	2188.46%
2018-06-30	124.09%
2018-03-31	130.32%
2017-12-31	136.17%
2017-09-30	-158.02%
2017-06-30	-129.19%
2017-03-31	-27.18%
2016-12-31	162.29%
2016-09-30	-209.13%
2016-06-30	-338.40%
2016-03-31	-1072.25%
2015-12-31	351.88%
2015-09-30	-196.76%
2015-06-30	-93.14%
2015-03-31	-84.14%
2014-12-31	-117.47%
2014-09-30	-309.09%
2014-06-30	-358.12%
2014-03-31	-172.19%
2013-12-31	638983.33%
2013-09-30	-111.16%
2013-06-30	-309.68%
2013-03-31	-111.98%
2012-12-31	-159.98%
2012-09-30	-358.40%
2012-06-30	-218.21%
2012-03-31	196.75%
2011-12-31	-272.45%
2011-09-30	-385.64%
2011-06-30	-150.43%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-38.96%
2024-12-31	-408.97%
2023-12-31	377.55%
2022-12-31	-1406.23%
2021-12-31	-112.29%
2020-12-31	-82.36%
2019-12-31	143.74%
2018-12-31	193.92%
2017-12-31	136.17%
2016-12-31	162.29%
2015-12-31	351.88%
2014-12-31	-117.47%
2013-12-31	638983.33%
2012-12-31	-159.98%
2011-12-31	-272.54%
2010-12-31	-493.54%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
uniQure N.V. (QURE)		$2.416B	-4.93
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Zai Lab Ltd (ZLAB)		$2.241B	-113.34